Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

OBJECTIVE: To evaluate the psychosocial impact of participation in a population-based prostate-specific antigen (PSA) testing programme, akin to screening, and to explore the relationship between urinary symptoms reported before PSA testing and the response to the subsequent PSA result. PATIENTS AN...

Podrobná bibliografie
Hlavní autoři:	Brindle, L, Oliver, SE, Dedman, D, Donovan, J, Neal, D, Hamdy, F, Lane, J, Peters, T
Médium:	Journal article
Jazyk:	English
Vydáno:	2006

Podobné jednotky

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
Autor: Moore, A, a další
Vydáno: (2009)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Autor: Avery, K, a další
Vydáno: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
Autor: Avery, K, a další
Vydáno: (2012)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Autor: Down, L, a další
Vydáno: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Autor: Down, L, a další
Vydáno: (2011)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Autor: J. Donovan, a další
Vydáno: (2003-01-01)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
Autor: Hamdy, F, a další
Vydáno: (2006)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Autor: Young, GJ, a další
Vydáno: (2017)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Autor: Hamdy, F, a další
Vydáno: (2006)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Autor: Macefield, R, a další
Vydáno: (2009)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
Autor: Hamdy, F, a další
Vydáno: (2006)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Autor: Avery, K, a další
Vydáno: (2008)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Autor: Oliver, SE, a další
Vydáno: (2004)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
Autor: Williams, N, a další
Vydáno: (2011)

Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities
Autor: Williams, N, a další
Vydáno: (2011)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
Autor: Neal, D, a další
Vydáno: (2006)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
Autor: Rosario, D, a další
Vydáno: (2008)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Autor: Simpkin, A, a další
Vydáno: (2013)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
Autor: Collin, S, a další
Vydáno: (2009)

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING
Autor: Burton, A, a další
Vydáno: (2011)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Autor: Harrison, S, a další
Vydáno: (2020)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
Autor: Vickers, A, a další
Vydáno: (2010)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Autor: Collin, S, a další
Vydáno: (2009)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Autor: Lane, J, a další
Vydáno: (2010)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
Autor: Collin, S, a další
Vydáno: (2010)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Autor: Turner, E, a další
Vydáno: (2011)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Autor: Tilling, K, a další
Vydáno: (2010)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Autor: Oliver, SE, a další
Vydáno: (2004)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Autor: Harrison, S, a další
Vydáno: (2016)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
Autor: Lane, J, a další
Vydáno: (2007)

Measurement of the insulin-like growth factor (IGF)-axis does not enhance the specificity of PSA-based prostate cancer screening.
Autor: Oliver, SE, a další
Vydáno: (2002)

Screening for prostate cancer. The case against.
Autor: Donovan, J, a další
Vydáno: (2005)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Autor: Avery, K, a další
Vydáno: (2007)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
Autor: Donovan, J, a další
Vydáno: (2003)

10-year outcomes in localized prostate cancer.
Autor: Hamdy, F, a další
Vydáno: (2017)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Autor: Lane, J, a další
Vydáno: (2009)

Prostate cancer: screening approaches.
Autor: Donovan, J, a další
Vydáno: (2005)